st 1435 has been researched along with norgestrel in 1 studies
| Studies (st 1435) | Trials (st 1435) | Recent Studies (post-2010) (st 1435) | Studies (norgestrel) | Trials (norgestrel) | Recent Studies (post-2010) (norgestrel) |
|---|---|---|---|---|---|
| 97 | 31 | 33 | 2,311 | 492 | 104 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammond, GL; Lähteenmäki, PL; Luukkainen, T | 1 |
1 other study(ies) available for st 1435 and norgestrel
| Article | Year |
|---|---|
Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacities.
Topics: Female; Humans; Injections, Subcutaneous; Norgestrel; Norpregnenes; Norprogesterones; Protein Binding; Sex Hormone-Binding Globulin; Transcortin | 1983 |